#Artificial Cornea and Corneal Implant market Trends | Explore Tumblr posts and blogs

insightfulblogz · 10 days ago

Text

Artificial Cornea and Corneal Implant Market Size, Share, Industry Analysis and Forecast 2024-2032

Artificial cornea and corneal implants have emerged as life-changing innovations in ophthalmology, addressing severe cases of corneal blindness and damage where traditional transplants are not viable. These implants mimic the structure and function of natural corneas, enabling vision restoration for patients with conditions like keratoconus, corneal scarring, and chemical injuries. With advancements in biocompatible materials and surgical techniques, artificial corneas are offering new hope for millions of visually impaired individuals.

The Artificial Cornea and Corneal Implant Market size was valued at USD 459.7 Million in 2023 and is expected to reach USD 813.7 Million By 2031 and grow at a CAGR of 7.4% over the forecast period of 2024-2031.

Future Scope

The future of artificial cornea and corneal implants is geared toward enhancing biocompatibility, reducing rejection rates, and improving surgical outcomes. Research into bioengineered corneas derived from patient cells is expected to revolutionize the field by eliminating the need for donor tissues. Additionally, the integration of nanotechnology is anticipated to improve implant durability and functionality. Efforts to make these solutions accessible in underserved regions are also gaining momentum, addressing global disparities in vision care.

Emerging Trends

Key trends in artificial cornea development include the use of hydrogels and collagen-based biomaterials for better integration with surrounding tissues. Minimally invasive surgical techniques are being refined to reduce recovery time and complications. Moreover, smart implants with embedded sensors are under exploration to monitor intraocular pressure and other vital parameters, offering a holistic approach to ocular health. These advancements reflect the growing convergence of biotechnology and digital innovation in ophthalmology.

Applications

Artificial corneas and corneal implants are primarily used to restore vision in patients with severe corneal damage who are unsuitable for donor corneal transplants. They are also employed in managing complex cases of corneal degeneration and trauma. In addition to therapeutic applications, these implants are being explored for use in refractive surgeries, further broadening their scope. Their success is contributing to advancements in regenerative medicine and ophthalmic research.

Key Points

Artificial corneas address severe cases of corneal blindness and damage.

Innovations include hydrogels, collagen-based biomaterials, and nanotechnology.

Bioengineered corneas derived from patient cells offer transformative potential.

Applications range from vision restoration to refractive surgery.

Smart implants with sensors are being developed for holistic ocular health monitoring.

Conclusion

Artificial cornea and corneal implants signify a major breakthrough in restoring vision for those previously deemed untreatable. The combination of biocompatible materials, advanced surgical techniques, and emerging technologies is driving their adoption worldwide. As research continues to push the boundaries of possibility, these implants are poised to reshape the future of vision care, offering improved quality of life for countless individuals.

Read More Details: https://www.snsinsider.com/reports/artificial-cornea-and-corneal-implant-market-3060

Contact Us:

Akash Anand — Head of Business Development & Strategy

Email: [email protected]

Phone: +1–415–230–0044 (US) | +91–7798602273 (IND)

#Artificial Cornea and Corneal Implant Market #Artificial Cornea and Corneal Implant Market Size #Artificial Cornea and Corneal Implant Market Share #Artificial Cornea and Corneal Implant Market Growth #Artificial Cornea and Corneal Implant Market Trends

0 notes

credenceresearchdotblog · 4 months ago

Text

The global demand for corneal implants was valued at USD 425.5 Million in 2022 and is expected to reach USD 720.2 Million in 2030, growing at a CAGR of 6.80% between 2023 and 2030.The corneal implants market is experiencing notable growth due to advancements in medical technology and increasing prevalence of corneal diseases. Corneal implants, also known as corneal inlays or grafts, are medical devices used to restore vision in patients with corneal disorders, including keratoconus, corneal dystrophies, and post-surgical complications. This article delves into the current trends, opportunities, and challenges shaping the corneal implants market.

Browse the full report at https://www.credenceresearch.com/report/corneal-implants-market

Market Overview

Corneal implants are designed to improve visual acuity and quality of life for individuals suffering from corneal conditions. These implants can be categorized into several types, including intracorneal rings, lamellar corneal grafts, and artificial corneas. Each type has unique applications and benefits, making them suitable for different patient needs.

The global corneal implants market has been expanding steadily, driven by factors such as increasing incidence of corneal diseases, rising geriatric population, and advancements in implant technology. According to market research reports, the market is expected to grow at a compound annual growth rate (CAGR) of approximately 7% over the next few years.

Current Trends

1. Technological Advancements: Recent innovations in corneal implant technology have significantly improved the efficacy and safety of these devices. Developments include the introduction of bioengineered implants and enhanced surgical techniques, which contribute to better outcomes and shorter recovery times for patients.

2. Rise in Refractive Surgery: The growing popularity of refractive surgeries, such as LASIK and PRK, has increased the demand for corneal implants to address complications and improve visual outcomes. Corneal inlays are particularly sought after for treating presbyopia and enhancing near vision in patients who have undergone refractive procedures.

3. Increasing Prevalence of Corneal Diseases: Corneal diseases, including keratoconus and Fuchs’ dystrophy, are becoming more prevalent globally. This rise is driving demand for effective treatment options, including corneal implants. Early diagnosis and advancements in medical research are further contributing to market growth.

4. Growing Awareness and Patient Preference: Increased awareness about corneal diseases and the availability of advanced treatment options are leading to higher patient adoption rates. Educational initiatives and improved patient access to healthcare are also playing a role in driving market expansion.

Opportunities

1. Emerging Markets: There is significant growth potential in emerging markets, where improving healthcare infrastructure and increasing awareness are creating new opportunities for corneal implant providers. Countries in Asia-Pacific and Latin America are experiencing rising demand for advanced medical solutions, including corneal implants.

2. Innovation and R&D: Continuous research and development in corneal implant technology present opportunities for market players to introduce innovative products. Collaborations with research institutions and investment in cutting-edge technologies can lead to the development of more effective and customizable implants.

3. Aging Population: The global aging population is a major driver for the corneal implants market. As the elderly are more prone to age-related eye conditions, there is a growing need for effective solutions to address their visual impairments.

Challenges

1. High Cost: The cost of corneal implants and associated surgical procedures can be a significant barrier for patients, particularly in developing regions. High costs may limit access to advanced treatments and impact overall market growth.

2. Regulatory and Approval Processes: The development and approval of corneal implants involve stringent regulatory requirements, which can delay market entry and increase costs for manufacturers. Navigating these regulatory landscapes requires substantial resources and expertise.

3. Complications and Risks: Although corneal implants offer numerous benefits, there are potential risks and complications associated with their use, such as infection, rejection, and visual disturbances. Ensuring the safety and effectiveness of these devices is crucial for maintaining patient trust and market growth.

Key Players

Mediphacos

Aurolab

CorneaGen

KeraMed, Inc

Presbia Plc

DIOPTEX

AJL Opthalmic SA

EyeYon Medical

CorNeat Vision

LinkoCare Life Sciences AB

Segmentation

By Type of Corneal Implants:

Penetrating Keratoplasty (PKP)

Deep Anterior Lamellar Keratoplasty (DALK)

Descemet’s Stripping Automated Endothelial Keratoplasty (DSAEK)

Descemet Membrane Endothelial Keratoplasty (DMEK)

By Source of Corneal Tissue:

Allografts

Synthetic Corneal Implants

By Indications:

Keratoconus

Corneal Scarring

Fuchs’ Endothelial Dystrophy

Bullous Keratopathy

Other Corneal Diseases

By Implant Material:

Human Corneal Tissue

Artificial Implants

By End Users:

Hospitals

Ambulatory Surgery Centers (ASCs)

Eye Banks

By Emerging Technologies:

3D-Printed Corneal Implants

Nanotechnology

Regenerative Medicine

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/corneal-implants-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: [email protected]

Website: www.credenceresearch.com

0 notes

health-views-updates · 8 months ago

Text

Artificial Cornea and Corneal Implant Market Growth, Size, Analysis, Outlook by 2024 - Trends, Opportunities and Forecast to 2031

The global artificial cornea and corneal implant market is poised for significant growth in the coming decade, with projections indicating a size reaching USD 746.45 million by 2030. This expansion is expected to occur at a Compound Annual Growth Rate (CAGR) of 7.2% between the forecast period of 2023-2030. Several factors contribute to this optimistic outlook, including emerging trends, key drivers propelling growth, and a host of opportunities. However, the market also faces challenges and considerations that stakeholders must navigate to fully capitalize on its potential.

Emerging Trends and Opportunities

One of the most promising trends in the artificial cornea and corneal implant market is the increasing adoption of advanced materials and technologies. Innovations in biomaterials, such as synthetic polymers and biocompatible metals, are enhancing the durability and biointegration of corneal implants. Additionally, the development of 3D printing technology has enabled the customization of implants to match the unique anatomical features of individual patients, leading to better surgical outcomes and patient satisfaction.

Moreover, the rising prevalence of corneal diseases and disorders worldwide presents a significant opportunity for market growth. Conditions such as keratoconus, corneal scarring, and corneal degeneration contribute to the growing demand for corneal transplantation and implantation procedures. As the global population ages and lifestyle factors such as increased screen time contribute to the incidence of corneal disorders, the need for effective treatment options is expected to escalate.

Furthermore, advancements in surgical techniques, such as Descemet's membrane endothelial keratoplasty (DMEK) and Descemet's stripping automated endothelial keratoplasty (DSAEK), are expanding the scope of corneal transplantation procedures. These minimally invasive techniques offer faster recovery times and improved visual outcomes compared to traditional full-thickness corneal transplantation, driving their adoption among ophthalmic surgeons and patients alike.

Download Free Sample Copy of Report: https://www.snsinsider.com/sample-request/3060

Key Drivers Propelling Growth

Several key drivers underpin the growth of the artificial cornea and corneal implant market. Foremost among these is the increasing prevalence of corneal diseases and disorders worldwide. Factors such as aging populations, the rising incidence of diabetes, and environmental factors like pollution and UV exposure contribute to the growing burden of corneal conditions, driving demand for treatment options.

Additionally, advancements in medical technology and surgical techniques are expanding the indications for corneal transplantation and implantation procedures. Improved understanding of corneal biomechanics, along with innovations in graft preparation and preservation, has led to higher success rates and better long-term outcomes for patients undergoing these procedures.

Moreover, the growing acceptance of artificial corneas and corneal implants among both patients and healthcare providers is fueling market growth. As the safety and efficacy of these devices continue to improve, they are increasingly viewed as viable alternatives to traditional donor corneal transplantation, particularly in cases where donor tissue may be scarce or unsuitable.

Challenges and Considerations

Despite the promising outlook for the artificial cornea and corneal implant market, several challenges and considerations must be addressed to realize its full potential. One of the primary challenges is the high cost associated with corneal transplantation and implantation procedures. While technological advancements have improved the efficacy of these interventions, they have also contributed to their increased expense, limiting access for patients in resource-constrained settings.

Furthermore, regulatory hurdles and reimbursement issues pose significant barriers to market entry and adoption. The approval process for new artificial corneas and corneal implants can be lengthy and complex, requiring extensive clinical trials to demonstrate safety and efficacy. Moreover, reimbursement policies vary between healthcare systems and payers, impacting the affordability and accessibility of these treatments for patients.

Additionally, the limited availability of skilled ophthalmic surgeons trained in advanced corneal transplantation techniques presents a bottleneck to market growth. As demand for these procedures continues to rise, efforts to expand training programs and build surgical capacity will be essential to meet the growing need for corneal care globally.

Key Takeaways from the Market

In summary, the artificial cornea and corneal implant market are poised for significant growth in the coming years, driven by emerging trends, key drivers propelling growth, and a host of opportunities. Advancements in materials science, surgical techniques, and medical technology are expanding the scope of corneal transplantation and implantation procedures, offering new hope to patients with corneal diseases and disorders.

However, challenges such as cost constraints, regulatory hurdles, and workforce shortages must be addressed to fully realize the market's potential. Collaborative efforts between industry stakeholders, regulatory agencies, healthcare providers, and patient advocacy groups will be essential to overcome these challenges and ensure equitable access to safe and effective corneal care for all patients in need. By leveraging emerging technologies and fostering innovation, the artificial cornea and corneal implant market can continue to drive positive outcomes and improve the quality of life for patients around the world.

0 notes

healtcareindustry23 · 2 years ago

Text

0 notes

vikaschauhanwriter · 3 years ago

Link

#Artificial Cornea and Corneal Implant Market Trends

0 notes

chetanare · 4 years ago

Text

Artificial Cornea and Corneal Implant Market Growth and Revenue Overview 2021 – by Size, Share, Product (Value, Volume and Types), Forecast to 2027

KandJMarketResearch.com add new report on “Global Artificial Cornea and Corneal Implant Market” covered new research with Covid-19 Outbreak Impact details. The global Artificial Cornea and Corneal Implant market survey report is compiled by industry analysts, and holds valuable insights into the industry. The global Artificial Cornea and Corneal Implant market survey report begins with a…

View On WordPress

0 notes

healthcare-market · 3 years ago

Text

Artificial Cornea Implant Market Detailed in New Research Report

Global Artificial Cornea Implant Market: Overview

The global artificial cornea implant market is likely to expand in the near future. This is mainly because of the increasing cases of corneal eye disease across the globe. The artificial cornea implant is a process of replacing damaged visual organ. The global artificial cornea implant market is growing mainly because artificial cornea implant helps to restore visual sharpness. This helps patients improve their vision.

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=61761

An upcoming report by Transparency Market Research on the global artificial cornea implant market will offer an in-depth analysis of key component of the market. Some of the key components are drivers, restrains, opportunity, trends. Further, the compilation will help elucidate the potential revenue across different segments of the global artificial cornea implant market. The study is vital to understand attractive investment prospects associated with the market. In addition to this, the report throws light on different segmentation of the global artificial cornea implant. Apart from this regional outlook and competitive strategy adopted by leading players will help readers predict growth in the global artificial cornea implant.

Request for Analysis of COVID19 Impact on Artificial Cornea Implant Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=61761

Global Artificial Cornea Implant Market: Trends and Opportunities

One of the primary drivers of the global artificial cornea implant market is rising prevalence of eye diseases across the globe. The growth in the artificial cornea implant market is attributed to the willingness of the customer to spend on eye care. Apart from this, increasing healthcare expenditure in developing countries on eye care is boosting the growth of the global artificial cornea implant market. In addition, factors such as increasing number of surgeries and rising demand for new techniques for the treatment provides a major impetus to the market.

Despite several drivers, high cost associated with cornea implant surgeries is posing a threat to the growth of the global artificial cornea implant market. Additionally, side effects of the cornea surgeries is preventing mass adoption of cornea implant. Nevertheless, new products and services offered by the key players in the artificial cornea implant market is estimated to fill up these gaps.

Request a Sample of Artificial Cornea Implant Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=61761

Global Artificial Cornea Implant Market: Geographical Analysis

Geographically, global artificial cornea implant market can be divided into North America, Europe, Asia-Pacific, South America, and Africa. Among all these regions, developed regions such as North America and Europe is projected to witness steady growth in the global artificial cornea implant market in the near future. This is due to the increasing number of eye care surgeries in the region.

Enquiry before Buying Artificial Cornea Implant Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=61761

Global Artificial Cornea Implant Market: Competitive Landscape

The competitive landscape of the global artificial cornea implant market displays a fierce competition. Key players are relying on advanced technology such as IoT, automation and cloud computing to stay ahead of their competitors in the artificial cornea market. New product launch and mergers and acquisition are the major strategies adopted by the top players in the corneal implant market space. Some of the prominent players operating in the global artificial cornea implant market are ReVision Optics, Neoptics, AcuFocus, KeraMed, Presbia, Powervision, Ocular Systems, Cornea Biosciences and DIOPTEX

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/cardiovascular-proximal-anastomosis-devices-market-to-reach-us-23-6-mn-by-2030--says-tmr-report-301494327.html

https://www.prnewswire.com/news-releases/medical-sensors-market-to-expand-with-increase-in-use-of-smartphones-high-speed-networks-and-sensors-states-tmr-study-301499814.html

https://www.prnewswire.com/news-releases/trauma-implants-market-to-reach-us-16-7-bn-by-the-end-of-2031--says-tmr-301504349.html

About Us Section:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Rohit Bhisey Transparency Market Research, 90 State Street, Suite 700, Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: [email protected]

Website: https://www.transparencymarketresearch.com/

0 notes

techsciresearch · 3 years ago

Link

According to TechSci Research report, Global Artificial Cornea & Corneal Implants Market stood at USD236.91 million in 2020 and is expected to grow at a robust rate of 15.29% by 2026.

Gain More Insights @ https://bit.ly/2XiiVNZ

Website: https://www.techsciresearch.com/

Market Research News: https://techsciblog.com/

#TechSci #Market Research Reports #Healthcare #Artificial Cornea #Eyecare #Global Artificial Cornea and Corneal Implants Market #Corneal Implants #Artificial Cornea and Corneal Implants Market #Healthcare Reports #Eye Health

0 notes

techscimarketresearch · 3 years ago

Link

According to TechSci Research report, Global Artificial Cornea & Corneal Implants Market stood at USD236.91 million in 2020 and is expected to grow at a robust rate of 15.29% by 2026.

Gain More Insights @ https://bit.ly/2XiiVNZ

Website: https://www.techsciresearch.com/

Market Research News: https://techsciblog.com/

#TechSci #Global Artificial Cornea and Corneal Implants Market #Healthcare #Market Research Reports #Artificial Cornea #Corneal Implants #Eyecare #Eye Health #Artificial Cornea and Corneal Implants Market #Healthcare Reports

0 notes

insightfulblogz · 2 months ago

Text

Artificial Cornea and Corneal Implant Market Report, Consumer Insights, Growth Prospects, Industry Outlook 2024-2032

Artificial cornea and corneal implant technologies have seen significant advancements, offering hope to individuals with corneal blindness or severe corneal damage. The cornea, the clear outer layer of the eye, plays a crucial role in focusing light and protecting the eye from infections. For patients with corneal diseases or injuries, traditional corneal transplants may not always be a viable solution due to the lack of donor tissue or the risk of rejection. Artificial corneas and implants are designed to address these challenges by providing a synthetic alternative that can restore vision and protect the eye. These innovations have the potential to reduce dependency on donor corneas and improve outcomes for patients with severe corneal conditions.

The Artificial Cornea and Corneal Implant Market size was valued at USD 459.7 Million in 2023 and is expected to reach USD 813.7 Million By 2031 and grow at a CAGR of 7.4% over the forecast period of 2024-2031.

Future Scope

The future of artificial cornea and corneal implants looks promising with ongoing research and development aimed at improving biocompatibility, durability, and optical performance. Scientists are exploring new materials, such as biomimetic and nanostructured polymers, which closely mimic the natural properties of the cornea while reducing the risk of rejection. Additionally, regenerative medicine and tissue engineering hold potential for developing bioengineered corneas that can integrate seamlessly with the patient’s own tissue. As these technologies evolve, artificial corneas may become the standard treatment for individuals with advanced corneal disease, especially in regions with limited access to donor tissue.

Trends

Several key trends are shaping the artificial cornea and corneal implant market. One major trend is the growing use of hybrid corneal implants, which combine synthetic materials with biological components to enhance biocompatibility and reduce rejection rates. Another trend is the development of minimally invasive implantation procedures, which reduce recovery times and improve patient comfort. In addition, there is a rising focus on expanding access to these technologies in developing countries, where corneal blindness is more prevalent due to the scarcity of donor tissue. Customizable implants that can be tailored to individual patients’ needs are also gaining traction as a way to improve visual outcomes.

Applications

Artificial cornea and corneal implants are primarily used to treat patients with severe corneal damage or disease, particularly those who are not eligible for traditional corneal transplants. This includes individuals with conditions such as keratoconus, chemical burns, or genetic corneal diseases. These implants are also used in cases where multiple transplant attempts have failed. Additionally, artificial corneas offer a solution for patients in regions with limited access to donor tissue, providing a long-term option for restoring vision.

Get Sample Copy of the Report: https://www.snsinsider.com/sample-request/3060

Key Points

Artificial corneas and corneal implants provide an alternative to traditional transplants.

They are used in patients with severe corneal damage, disease, or multiple transplant failures.

The market is driven by advancements in biomaterials and regenerative medicine.

Key trends include hybrid implants, minimally invasive procedures, and global accessibility.

Future research focuses on improving biocompatibility and developing bioengineered corneas.

Conclusion

The development of artificial cornea and corneal implant technologies is a groundbreaking advancement in vision restoration. As research continues to improve the safety, efficacy, and accessibility of these solutions, they offer a lifeline to individuals suffering from corneal blindness or damage. With ongoing innovations in biomaterials and tissue engineering, the future of corneal implants holds the potential to significantly reduce the global burden of corneal blindness, offering hope for millions of patients worldwide.

#Artificial Cornea and Corneal Implant Market

0 notes

apurvafmi-blog · 6 years ago

Link

Artificial cornea implant is a surgery to eliminate all or part of a damaged cornea and replace it with healthy donor tissue. But, currently there shortage of cornea donor worldwide and eye and tissue banking is also not carrying in many countries. Meanwhile there is always possibility that human eye will reject the transplantation which can cause infection or lack of vision. Cornea Implant is usually performed under certain condition such as keratoconus, degenerative condition or other. The artificial cornea tissue can be made up of polymer plastic such as silica material. Artificial cornea implant are of two type, i.e. synthetic cornea implant and biosynthetic cornea implant. Generally, biosynthetic cornea implantation include immunosuppression and preventive measure should be taken for six month to one year. Whereas, synthetic cornea implant do not include immunosuppression and preventive measure should be taken for seven weeks.

Request Sample Report@ https://www.persistencemarketresearch.com/samples/23152

Around 10 million people in world suffering from corneal blindness. Therefore, rising incidences of corneal blindness is the primary factor driving the growth of artificial cornea implant. Moreover, lack of availability of human cornea donor also responsible for the robust growth of this market. Additionally increasing incidences of trauma cases lead to high chances of eye injury which will also propel the growth of this market. The possibility of nerve regeneration after cornea transplant by human donor cornea is low while biosynthetic cornea implant have high possibility of nerve regeneration after implantation. The rejection of artificial cornea made up of alloplastic material by human eye will be the major factor that can restrain the global market of artificial cornea implant. Artificial cornea implant is the costly surgery, therefore the adoption for this surgery is quite low in developing countries which will also deter the growth of this market over the forecast period. Additionally, low availability of human cornea donor and high risk in the grafting artificial cornea implant have made their huge impact the global market.

The global market of artificial cornea implant is classified on the basis of implant type, indication and end user.

Based on type of implant global market of artificial cornea implant is segmented into the following

Synthetic Implant

Biosynthetic Implant

Based on disease indication global market of artificial cornea implant is segmented into the following

Bullous keratopathy

Keratoconus

Keratitis

Corneal stromal dystrophies

Others

Based on end user global market of artificial cornea implant is segmented into the following

Hospitals

Ambulatory Surgical Centers

The artificial cornea implant market is expected to grow exponentially over the forecast period due to increasing incidence of corneal infection. There is increase in visual disability due to cloudy cornea for working people which has increased demand of cornea implant in global market. Biosynthetic cornea implant is preferred over synthetic cornea implant by most of the ambulatory surgical centers. Therefore, biosynthetic cornea implant is expected to gain maximum market share by implant type for global artificial corneal implant market. Synthetic cornea implant have used only for severely injured connective tissue. Due to this synthetic implant has less market demand over biosynthetic demand. The crafting of biosynthetic cornea require manual work and it also costly method. It is expected that biosynthetic cornea implant would have huge market demand in near future.

Request TOC@ https://www.persistencemarketresearch.com/methodology/23152

On the basis of geography, artificial corneal implant market is classified in six key region viz. North America, Latin America, Europe, Asia-Pacific excluding China, China, Middle East and Africa. North America is expected to dominate the revenue share by region which is the followed by Europe though more than 90% of biosynthetic cornea implant performed in Europe and United States. During a survey in 2016 it is clarified that 64% of people in U.K. have rejected to donate their cornea for transplantation which has expand the growth cornea implant market globally. Asia Pacific region India and China are low cost market for cornea implant, therefore it is the best place for people who are planning medical tourism. There is dramatic increase in cornea implant market in Middle East Africa Latin America owing to less adoption artificial cornea implant in this region.

Some of the major key player for Artificial Cornea Implant market globally are F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals, Inc., Pfizer, Inc., Bayer AG, Bausch & Lomb Incorporated. Another prominent player in the macular edema markets are Aciont Inc., ActiveSite, Pharmaceuticals, Inc., Adverum Biotechnologies, Inc., Aerpio Therapeutics, Inc., Ampio Pharmaceuticals, Inc., Araim Pharmaceuticals, Inc., Astellas Pharma Inc.,Boehringer , Ingelheim GmbH.

#Artificial Cornea Implant Market

0 notes

mountainghost-blog · 6 years ago

Text

Impact of Existing and Emerging Artificial Cornea Implant Market Trends 2018-2026

Artificial cornea implant is a surgery to eliminate all or part of a damaged cornea and replace it with healthy donor tissue. But, currently there shortage of cornea donor worldwide and eye and tissue banking is also not carrying in many countries. Meanwhile there is always possibility that human eye will reject the transplantation which can cause infection or lack of vision. Cornea Implant is usually performed under certain condition such as keratoconus, degenerative condition or other.

The artificial cornea tissue can be made up of polymer plastic such as silica material. Artificial cornea implant are of two type, i.e. synthetic cornea implant and biosynthetic cornea implant. Generally, biosynthetic cornea implantation include immunosuppression and preventive measure should be taken for six month to one year. Whereas, synthetic cornea implant do not include immunosuppression and preventive measure should be taken for seven weeks.

Around 10 million people in world suffering from corneal blindness. Therefore, rising incidences of corneal blindness is the primary factor driving the growth of artificial cornea implant. Moreover, lack of availability of human cornea donor also responsible for the robust growth of this market. Additionally increasing incidences of trauma cases lead to high chances of eye injury which will also propel the growth of this market. The possibility of nerve regeneration after cornea transplant by human donor cornea is low while biosynthetic cornea implant have high possibility of nerve regeneration after implantation.

Request Report Sample@https://www.persistencemarketresearch.com/samples/23152

The rejection of artificial cornea made up of alloplastic material by human eye will be the major factor that can restrain the global market of artificial cornea implant. Artificial cornea implant is the costly surgery, therefore the adoption for this surgery is quite low in developing countries which will also deter the growth of this market over the forecast period. Additionally, low availability of human cornea donor and high risk in the grafting artificial cornea implant have made their huge impact the global market.

The global market of artificial cornea implant is classified on the basis of implant type, indication and end user: Based on type of implant global market of artificial cornea implant is segmented into the following: Synthetic Implant, Biosynthetic Implant; Based on disease indication global market of artificial cornea implant is segmented into the following: Bullous keratopathy, Keratoconus, Keratitis, Corneal stromal dystrophies, Others; Based on end user global market of artificial cornea implant is segmented into the following: Hospitals, Ambulatory Surgical Centers.

The artificial cornea implant market is expected to grow exponentially over the forecast period due to increasing incidence of corneal infection. There is increase in visual disability due to cloudy cornea for working people which has increased demand of cornea implant in global market. Biosynthetic cornea implant is preferred over synthetic cornea implant by most of the ambulatory surgical centers. Therefore, biosynthetic cornea implant is expected to gain maximum market share by implant type for global artificial corneal implant market. Synthetic cornea implant have used only for severely injured connective tissue. Due to this synthetic implant has less market demand over biosynthetic demand. The crafting of biosynthetic cornea require manual work and it also costly method. It is expected that biosynthetic cornea implant would have huge market demand in near future.

On the basis of geography, artificial corneal implant market is classified in six key region viz. North America, Latin America, Europe, Asia-Pacific excluding China, China, Middle East and Africa. North America is expected to dominate the revenue share by region which is the followed by Europe though more than 90% of biosynthetic cornea implant performed in Europe and United States. During a survey in 2016 it is clarified that 64% of people in U.K. have rejected to donate their cornea for transplantation which has expand the growth cornea implant market globally. Asia Pacific region India and China are low cost market for cornea implant, therefore it is the best place for people who are planning medical tourism. There is dramatic increase in cornea implant market in Middle East Africa Latin America owing to less adoption artificial cornea implant in this region.

Visit For TOC@https://www.persistencemarketresearch.com/toc/23152

Some of the major key player for Artificial Cornea Implant market globally are F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals, Inc., Pfizer, Inc., Bayer AG, Bausch & Lomb Incorporated. Another prominent player in the macular edema markets are Aciont Inc., ActiveSite, Pharmaceuticals, Inc., Adverum Biotechnologies, Inc., Aerpio Therapeutics, Inc., Ampio Pharmaceuticals, Inc., Araim Pharmaceuticals, Inc., Astellas Pharma Inc.,Boehringer , Ingelheim GmbH.

Full Report Analysis@https://www.persistencemarketresearch.com/market-research/artificial-cornea-implant-market.asp

#healthcare

0 notes

techsciresearch · 3 years ago

Text

Artificial Cornea and Corneal Implants Market to grow at an Impressive CAGR During the Forecast Period | TechSci Research

Increasing prevalence of ophthalmic diseases is supporting the growth of Global Artificial Cornea and Corneal Implants Market.

According to TechSci Research report, “Global Artificial Cornea and Corneal Implants Market By Type (Human Cornea v/s Artificial Cornea) By Transplant Type (Penetrating Keratoplasty v/s Endothelial Keratoplasty) By Disease Indication (Fuchs’ Dystrophy, Keratoconus, Fungal Keratitis, Others) By End User (Hospitals, Ambulatory Care Centers, Others) By Region, Competition Forecast & Opportunities, 2026”, the global artificial cornea and corneal implants market is anticipated to show robust growth in the upcoming five years owing to the major factors like rising population of the old people. Older population have a tendency of contracting various high-risk eye diseases, also vision impairment and corneal rupture is quite frequent in the geriatric population, supporting the growth of global artificial cornea and corneal implants market in the next five years.

Moreover, organizations like Eye Bank Association of America (EBAA) and The Global Alliance of Eye Bank Associations are creating a lot of awareness and are promoting policies regarding effective corneal transplantation and encouraging the patients to choose the procedure. This factor is actively supporting the global artificial cornea and corneal implants market growth in the next five years. Additionally, the market experiences a surge in demand of non-invasive or minimally invasive procedure for various medical diagnostic and surgical requirements thereby boosting the growth of global artificial cornea and corneal implants market from 2022 to 2026.

Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Global Artificial Cornea and Corneal Implants Market"

https://www.techsciresearch.com/report/artificial-cornea-and-corneal-implants-market/7608.html

The global artificial cornea and corneal implants market is segmented by type, transplantation type, disease indication, end user, competitional landscape and regional distribution. Based on transplantation type the market is further segmented into penetrating keratoplasty v/s endothelial keratoplasty. Penetrating keratoplasty is the dominant market segment with the largest shares in the historical period. Penetrating keratoplasty is also anticipated to assert its dominance over the market in the upcoming five years, owing its growth to the safety and efficiency of the procedure. Although the market segment faces a minor threat from its alternate procedure; endothelial keratoplasty.

Endothelial keratoplasty is anticipated to record fastest growth in the upcoming market owing its growth to the promising results the procedure shows. The endothelial keratoplasty is the latest approach in the market and involves minimal invasion like it only replaces the affected tissue rather than the complete cornea. Availability of the human cornea for the replacement is an issue that becomes null and void because of the efficiency of the endothelial keratoplasty procedure. Moreover, the procedure helps with the faster and better visual restoration with decreased risk of eye infection and any pother accidental mishaps during procedure. Also, growing prevalence of Fuchs dystrophy is anticipated to support the robust growth of the market segment.

Based on disease indication, the market is further bifurcated into Fuchs’ dystrophy, keratoconus, fungal keratitis, and others. Rising geriatric population is quite susceptible to contracting Fuchs’ dystrophy. The disease held the largest as well as the fastest growing market share. It is anticipated to assert its dominance in the forecast period too. Keratoconus disease held the significant share of market too, rising number of the patient suffering from keratoconus often reach the stage where they require corneal implant to regain their normal vision. Advanced procedures like Deep Anterior Lamellar Keratoplasty (DALK) bestows the advantage, the factor, along with FDA approved corneal implants are major drivers of the market growth in the forecast period.

Top players of the market are F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals, Inc, Alcon, Inc., Bayer AG, Bausch & Lomb Incorporated, AJL Ophthalmic S.A., CorneaGen Inc., Addition Technology, Inc., LinkoCare Life Sciences AB, Presbia plc, Mediphacos, Aurolab (Aravind Eye Care System), LinCor Biosciences, Pte. Ltd. (Cornea Biosciences), DIOPTEX GmbH, EyeYon Medical Ltd.., among others. Other strategies include partnerships among the players and technologically advanced product launches.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7608

Customers can also request for 10% free customization on this report.

“Major players of the market are headquartered in the North American region. The efficient reimbursement policies by the government of large economies like United States in the region, make North America the dominating sector for the market. Moreover, the players are actively involved in the research and development of the implants and efficient processes thereby supporting the market growth in the forecast period. Asia Pacific region is expected to be fastest growing market. New markets in the developing countries are emerging and the cost-effective procedures in these countries would help strengthen the market in countries like China, Indonesia, Philippines,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.

“Global Artificial Cornea and Corneal Implants Market By Type (Human Cornea v/s Artificial Cornea) By Transplant Type (Penetrating Keratoplasty v/s Endothelial Keratoplasty) By Disease Indication (Fuchs’ Dystrophy, Keratoconus, Fungal Keratitis, Others) By End User (Hospitals, Ambulatory Care Centers, Others) By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of global artificial cornea and corneal implants and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global artificial cornea and corneal implants.

Browse Related Reports:

Global Autoinjectors Market By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Others) By Design (Standardized v/s Customized) By Product (Prefilled v/s Fillable) By Technology (Automated v/s Manual) By Type (Disposable v/s Reusable) By Route of Administration (Intravenous v/s Subcutaneous) By End User (Hospitals & Clinics, Ambulatory Care Settings, Home Care Settings) By Region, Competition Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/autoinjectors-market/7341.html

Global Foot & Ankle Devices Market By Product Type (Joint Implants, Fixation Devices, Soft Tissue Orthopedic Devices, Bracing & Support Devices, Prostheses) By Procedure (Osteotomy, Fracture Repair, Fusion Procedures, Others) By Application (Trauma & Hair line Fractures, Rheumatoid Arthritis & Osteoarthritis, Diabetic Foot Diseases, Ligament Injuries, Others) By End User (Hospitals, Ambulatory Surgery Centers, Orthopedic Clinics, Rehabilitation Centers) By Region, Competition Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/foot-and-ankle-devices-market/7342.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: https://www.techsciresearch.com/

For More Market Research Blogs Visit: https://techsciblog.com/

#TechSci #Market Research Reports #Healthcare #Medical Devices #Eyecare #Global Artificial Cornea and Corneal Implants Market #EyeHealthcare #Artificial Cornea and Corneal Implants Market #Artificial Cornea and Corneal Implants Market Size #Artificial Cornea and Corneal Implants Market Forecast

0 notes

techscimarketresearch · 3 years ago

Text

Artificial Cornea and Corneal Implants Market to grow at an Impressive CAGR During the Forecast Period | TechSci Research

Increasing prevalence of ophthalmic diseases is supporting the growth of Global Artificial Cornea and Corneal Implants Market.